Company news
Collegium Pharmaceutical, Inc. news in 2020
Collegium Pharmaceutical, Inc.'s news releases, calls and decks from 2020, newest first.
Collegium Reports Net Income of $11.3 Million in the Third Quarter of 2020
November 4, 2020
Collegium Announces Publication of “Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza® ER” in Pain Medicine
October 25, 2020
Collegium to Host Conference Call to Discuss Third Quarter 2020 Financial Results and Provide Corporate Update
October 21, 2020
Collegium Announces Settlement with Teva Resolving Xtampza® ER Patent Litigation
September 29, 2020
Collegium Appoints Rita Balice-Gordon to its Board of Directors
September 24, 2020
Collegium Announces Five Posters Presented at PAINWeek 2020 National Conference
September 13, 2020
Collegium Announces Scientific Presentations at PAINWeek 2020 National Conference
September 8, 2020
Collegium Reports Net Income of $8.1 Million in the Second Quarter of 2020
August 4, 2020
Collegium to Host Conference Call to Discuss Second Quarter 2020 Financial Results and Provide Corporate Update
July 20, 2020
Collegium Pharmaceutical Named one of Boston Business Journal’s 2020 Best Places to Work
June 16, 2020
Collegium Reports First Quarter 2020 Profitability
May 6, 2020
Collegium to Host Conference Call to Discuss First Quarter 2020 Financial Results and Provide Corporate Update
April 22, 2020
Collegium Reports Full-Year 2019 Revenue of $296.7 Million
February 26, 2020
Collegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Provide Corporate Update
February 25, 2020
Collegium Announces Closing of the Nucynta Franchise Acquisition
February 12, 2020
Collegium Pharmaceutical, Inc. Prices $125.0 Million Convertible Senior Notes Offering
February 9, 2020
Collegium to Acquire U.S. Rights to Nucynta Franchise
February 5, 2020
Collegium Provides 2020 Financial Guidance
January 6, 2020